EP1311202A4 - Verfahren und vorrichtung zur revision der antikoagulantdosis - Google Patents

Verfahren und vorrichtung zur revision der antikoagulantdosis

Info

Publication number
EP1311202A4
EP1311202A4 EP01963959A EP01963959A EP1311202A4 EP 1311202 A4 EP1311202 A4 EP 1311202A4 EP 01963959 A EP01963959 A EP 01963959A EP 01963959 A EP01963959 A EP 01963959A EP 1311202 A4 EP1311202 A4 EP 1311202A4
Authority
EP
European Patent Office
Prior art keywords
anticoagulant dose
revision
dose revision
anticoagulant
dose
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
EP01963959A
Other languages
English (en)
French (fr)
Other versions
EP1311202A1 (de
Inventor
John D Kutzko
Michaeal G Singer
John Mcmichael
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dimensional Dosing Systems Inc
Original Assignee
Dimensional Dosing Systems Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/644,503 external-priority patent/US6942614B1/en
Application filed by Dimensional Dosing Systems Inc filed Critical Dimensional Dosing Systems Inc
Priority claimed from CA002401913A external-priority patent/CA2401913A1/en
Publication of EP1311202A1 publication Critical patent/EP1311202A1/de
Publication of EP1311202A4 publication Critical patent/EP1311202A4/de
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Surgery (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EP01963959A 2000-08-24 2001-08-13 Verfahren und vorrichtung zur revision der antikoagulantdosis Ceased EP1311202A4 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US644503 1991-01-23
US09/644,503 US6942614B1 (en) 1999-07-06 2000-08-24 Method and system for use in treating a patient with an anticoagulant to optimize therapy and prevent an adverse drug response
PCT/US2001/025362 WO2002019935A1 (en) 2000-08-24 2001-08-13 Method and system for anticoagulant dose revision
CA002401913A CA2401913A1 (en) 1999-07-06 2002-09-06 Method, apparatus and system for use in treating patient with a drug having an antineoplastic effect to optimize therapy and prevent an adverse drug response

Publications (2)

Publication Number Publication Date
EP1311202A1 EP1311202A1 (de) 2003-05-21
EP1311202A4 true EP1311202A4 (de) 2007-04-18

Family

ID=32928334

Family Applications (1)

Application Number Title Priority Date Filing Date
EP01963959A Ceased EP1311202A4 (de) 2000-08-24 2001-08-13 Verfahren und vorrichtung zur revision der antikoagulantdosis

Country Status (3)

Country Link
EP (1) EP1311202A4 (de)
AU (1) AU2001284868A1 (de)
WO (1) WO2002019935A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050154537A1 (en) * 2003-12-12 2005-07-14 Kutzko John D. Methods, program products, and systems for single and multi-agent dosing and other related methods

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001002050A2 (en) * 1999-07-06 2001-01-11 The Rxfiles Corporation Method and system for use in treating a patient with any drug to optimize therapy and prevent an adverse drug response

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5694950A (en) * 1992-08-21 1997-12-09 J & W Mcmichael Software, Inc. Method and system for use in treating a patient with immunosuppresants using whole blood level criteria to prevent an adverse immune response
US5365948A (en) * 1992-08-21 1994-11-22 J & W Mcmichael Software Inc. Method for use in treating a patient with FK 506 to prevent an adverse immune response

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001002050A2 (en) * 1999-07-06 2001-01-11 The Rxfiles Corporation Method and system for use in treating a patient with any drug to optimize therapy and prevent an adverse drug response

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
ANSELL J ET AL: "Managing oral anticoagulant therapy.", CHEST JAN 2001, vol. 119, no. 1 Suppl, January 2001 (2001-01-01), pages 22S - 38S, XP002419348, ISSN: 0012-3692 *
POLLER ET AL: "Multicentre randomised study of computerised anticoagluant dosage", THE LANCET, vol. 352, pages 1505 - 1509, XP004265723 *
See also references of WO0219935A1 *

Also Published As

Publication number Publication date
AU2001284868A1 (en) 2002-03-22
EP1311202A1 (de) 2003-05-21
WO2002019935A1 (en) 2002-03-14

Similar Documents

Publication Publication Date Title
GB2358937B (en) Method and system for natural language understanding
GB0021378D0 (en) Method and system for natural language understanding
GB2368432B (en) System and method for language extraction and encoding
GB0028079D0 (en) System and method
IL153564A0 (en) Method and system for modeling biological systems
GB2379764B (en) System and method for file system mandatory access control
IL158367A0 (en) System and method for phytomonitoring
HK1045777A1 (zh) 用於迷你向導實施的系統與方法
EP1295617A4 (de) Automatischer dialysator und dialyseverfahren
GB2365578B (en) System and method for synchronizing databases
AU2002228836A1 (en) System and method for allocating operating expenses
IL138123A0 (en) Medical decision support system and method
AU2002222170A1 (en) Method and system for icosaborane implantation
AU2002248172A1 (en) System and method for fitting shoes
AU2001295863A1 (en) Method system and apparatus for multiprocessing
AU2001280045A1 (en) Method and system for ensuring approved weighing
GB2372417B (en) Method and system for delivering music
GB0019500D0 (en) System and method
EP1311202A4 (de) Verfahren und vorrichtung zur revision der antikoagulantdosis
GB2350984B (en) Synchronisation method and system
EP1343416A4 (de) Stentablegesystem und verfahren
GB2377345B (en) Time synchronisation system and method
GB0008434D0 (en) Editing system and method
IL140241A0 (en) Interactive searching system and method
GB0105509D0 (en) Detector system and method

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20030227

AK Designated contracting states

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

AX Request for extension of the european patent

Extension state: AL LT LV MK RO SI

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: DIMENSIONAL DOSING SYSTEMS, INC.

RIC1 Information provided on ipc code assigned before grant

Ipc: A61P 7/02 20060101ALI20070302BHEP

Ipc: A61K 31/00 20060101AFI20070302BHEP

A4 Supplementary search report drawn up and despatched

Effective date: 20070315

17Q First examination report despatched

Effective date: 20070514

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN REFUSED

18R Application refused

Effective date: 20081015